Seifarth W - Search Results

1

Reverse Transcription Can Critically Impact the Diagnostic Outcome of BCR::ABL1 Quantitative Real-Time RT-PCR.

Spiess B, Kleiner H, Tarnopolscaia I, Naumann N, Fabarius A, Hofmann WK, Saussele S, Seifarth W. Spiess B, et al. Among authors: seifarth w. Cancers (Basel). 2023 Aug 1;15(15):3914. doi: 10.3390/cancers15153914. Cancers (Basel). 2023. PMID: 37568730 Free PMC article.

2

The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.

Spiess B, Naumann N, Galuschek N, Rinaldetti S, Kossak-Roth U, Tarnopolscaia I, Felde E, Fabarius A, Hofmann WK, Saußele S, Seifarth W. Spiess B, et al. Among authors: seifarth w. PLoS One. 2018 Apr 24;13(4):e0196326. doi: 10.1371/journal.pone.0196326. eCollection 2018. PLoS One. 2018. PMID: 29689094 Free PMC article.

3

Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials.

Spiess B, Rinaldetti S, Naumann N, Galuschek N, Kossak-Roth U, Wuchter P, Tarnopolscaia I, Rose D, Voskanyan A, Fabarius A, Hofmann WK, Saußele S, Seifarth W. Spiess B, et al. Among authors: seifarth w. PLoS One. 2019 Mar 21;14(3):e0214305. doi: 10.1371/journal.pone.0214305. eCollection 2019. PLoS One. 2019. PMID: 30897165 Free PMC article.

4

A new aberrantly spliced BCR-ABL1 transcript variant (e13a1) identified in routine monitoring using different quantitative reverse transcription polymerase chain reaction techniques in a patient with chronic myeloid leukemia.

Naumann N, Bross-Bach U, Seifarth W, Fabarius A, Hofmann WK, Saußele S, Spiess B. Naumann N, et al. Among authors: seifarth w. EJHaem. 2022 Sep 2;3(4):1339-1342. doi: 10.1002/jha2.553. eCollection 2022 Nov. EJHaem. 2022. PMID: 36467807 Free PMC article.

5

Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML.

Christiani E, Naumann N, Weiss C, Spiess B, Kleiner H, Fabarius A, Hofmann WK, Saussele S, Seifarth W. Christiani E, et al. Among authors: seifarth w. Cancers (Basel). 2023 May 8;15(9):2652. doi: 10.3390/cancers15092652. Cancers (Basel). 2023. PMID: 37174118 Free PMC article.

6

c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia.

Prinzhorn W, Stehle M, Kleiner H, Ruppenthal S, Müller MC, Hofmann WK, Fabarius A, Seifarth W. Prinzhorn W, et al. Among authors: seifarth w. Biomark Res. 2016 Mar 2;4:5. doi: 10.1186/s40364-016-0059-2. eCollection 2016. Biomark Res. 2016. PMID: 26937281 Free PMC article.

7

Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies.

Kohl V, Flach J, Naumann N, Brendel S, Kleiner H, Weiss C, Seifarth W, Nowak D, Hofmann WK, Fabarius A, Popp HD. Kohl V, et al. Among authors: seifarth w. Cancers (Basel). 2019 Oct 3;11(10):1493. doi: 10.3390/cancers11101493. Cancers (Basel). 2019. PMID: 31623402 Free PMC article.

8

DNA Damage and DNA Damage Response in Chronic Myeloid Leukemia.

Popp HD, Kohl V, Naumann N, Flach J, Brendel S, Kleiner H, Weiss C, Seifarth W, Saussele S, Hofmann WK, Fabarius A. Popp HD, et al. Among authors: seifarth w. Int J Mol Sci. 2020 Feb 11;21(4):1177. doi: 10.3390/ijms21041177. Int J Mol Sci. 2020. PMID: 32053969 Free PMC article.

9

Separase activity distribution can be a marker of major molecular response and proliferation of CD34⁺ cells in TKI-treated chronic myeloid leukemia patients.

Spiess B, Kleiner H, Flach J, Fabarius A, Saussele S, Hofmann WK, Seifarth W. Spiess B, et al. Among authors: seifarth w. Ann Hematol. 2020 May;99(5):991-1006. doi: 10.1007/s00277-020-04007-4. Epub 2020 Apr 6. Ann Hematol. 2020. PMID: 32253454 Free PMC article. Clinical Trial.

10

Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells.

Fabarius A, Samra V, Drews O, Mörz H, Bierbaum M, Darwich A, Weiss C, Brendel S, Kleiner H, Seifarth W, Greffrath W, Hofmann WK, Schmitt CA, Popp HD. Fabarius A, et al. Among authors: seifarth w. Cancers (Basel). 2022 Jun 11;14(12):2883. doi: 10.3390/cancers14122883. Cancers (Basel). 2022. PMID: 35740549 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page